Published in Am J Pathol on July 01, 1993
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
Review part 2: Human herpesvirus-6 in central nervous system diseases. J Med Virol (2010) 1.05
Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol (1994) 1.05
Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. Proc Natl Acad Sci U S A (2011) 0.95
NKG2D contributes to efficient clearance of picornavirus from the acutely infected murine brain. J Neurovirol (2008) 0.95
The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells. J Virol (1995) 0.92
The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog (2007) 0.90
Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system. J Virol (1996) 0.89
The GDVII strain of Theiler's virus spreads via axonal transport. J Virol (1999) 0.88
Mode of spread to and within the central nervous system after oral infection of neonatal mice with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1995) 0.86
B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease. J Virol (1995) 0.82
Specific infection and destruction of dopaminergic neurons in the substantia nigra by Theiler's virus. J Virol (1997) 0.77
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun (1975) 7.12
Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest (1975) 3.45
Observations on encephalomyelitis of mice (DA strain). J Exp Med (1952) 2.68
Theiler's virus persists in glial cells during demyelinating disease. Cell (1981) 2.67
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science (1986) 2.61
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol (1983) 2.60
Theiler's virus-induced demyelination: prevention by immunosuppression. Science (1976) 2.59
Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J Immunol (1986) 1.76
Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol (1987) 1.65
DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann Neurol (1984) 1.62
Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest (1986) 1.53
Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol (1989) 1.49
Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells. J Virol (1988) 1.41
Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect Immun (1977) 1.33
Cholinergic and GABAergic afferents to the olfactory bulb in the rat with special emphasis on the projection neurons in the nucleus of the horizontal limb of the diagonal band. J Comp Neurol (1986) 1.30
Serotonergic afferents to the rat olfactory bulb: I. Origins and laminar specificity of serotonergic inputs in the adult rat. J Neurosci (1987) 1.23
The distribution of herpes simplex type 1 antigen in mouse central nervous system after different routes of inoculation. J Neurol Sci (1983) 1.22
Neuronal and transneuronal tracing in the trigeminal system of the rat using the herpes virus suis. Brain Res (1983) 1.21
The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol (1990) 1.20
The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J Gen Virol (1992) 1.13
Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med (1990) 1.08
Pathogenesis of neurovirulent influenza A virus infection in mice. Route of entry of virus into brain determines infection of different populations of cells. Lab Invest (1983) 1.06
A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis. J Cereb Blood Flow Metab (1985) 0.88
Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation. Immunology (1992) 0.84
Distribution of Theiler's virus in the CNS of athymic nude mice: effect of varying the route of inoculation. J Neurol Sci (1987) 0.83
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 3.68
Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 2.12
Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature (1979) 1.75
Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol (1996) 1.67
A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J Virol (1989) 1.59
Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest (1986) 1.53
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol (1983) 1.46
Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol (1980) 1.45
Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology (1997) 1.41
Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells. J Virol (1988) 1.41
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med (1989) 1.39
Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J Exp Med (1986) 1.24
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol (1990) 1.20
Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J Infect Dis (1989) 1.19
Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol (2000) 1.17
Characterization of in vitro transcription and transcriptional products of measles virus. J Virol (1987) 1.14
Failure to cleave measles virus fusion protein in lymphoid cells. J Exp Med (1981) 1.13
Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol (1998) 1.11
Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol (1997) 1.09
Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med (1990) 1.08
Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell. Virology (1983) 1.07
Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol (1994) 1.05
Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol (1999) 1.04
Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. J Virol (1991) 1.03
Viruses can silently prime for and trigger central nervous system autoimmune disease. J Neurovirol (2001) 1.03
Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen. Prog Med Virol (1980) 1.02
Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus. Microb Pathog (1995) 1.00
Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants. J Immunol (1981) 0.98
Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol (1999) 0.98
Antigenic modulation induced by monoclonal antibodies: antibodies to measles virus hemagglutinin alters expression of other viral polypeptides in infected cells. J Immunol (1984) 0.97
Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J Neuroimmunol (2000) 0.96
Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. J Virol (1991) 0.96
Pathogenesis of Theiler's murine encephalomyelitis virus. Adv Virus Res (1991) 0.95
Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1993) 0.94
Molecular mimicry: a mechanism for autoimmune injury. FASEB J (1992) 0.93
Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol (1999) 0.91
Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression. Virology (1997) 0.91
Purification of measles virus glycoproteins and their integration into artificial lipid membranes. J Gen Virol (1981) 0.91
Serologic relatedness between Thy-1.2 and actin revealed by monoclonal antibody. J Immunol (1983) 0.89
DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J Virol (1999) 0.88
Experimental allergic encephalomyelitis in suckling Lewis rats: comparison with the disease in adult animals. Lab Invest (1977) 0.87
Cellular transfer of experimental allergic encephalomyelitis employing suckling and adult Lewis rats. J Clin Lab Immunol (1981) 0.87
Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression. Virology (1998) 0.86
Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen. J Immunol (1977) 0.86
Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. J Neuroimmunol (1998) 0.85
Lipopeptide particles as the immunologically active component of CTL inducing vaccines. Vaccine (1999) 0.85
Effects of regional spinal X-irradiation on demyelinating disease caused by Theiler's virus, mouse hepatitis virus or experimental allergic encephalomyelitis. J Neuroimmunol (1987) 0.83
Antigenic mimicry between measles virus and human T lymphocytes. J Infect Dis (1987) 0.83
Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10. J Neuroimmunol (1998) 0.83
Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis. J Neuroimmunol (1999) 0.83
Antisense-mediated resistance to measles virus infection in HeLa cells. J Infect Dis (1997) 0.82
Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J Neuroimmunol (1996) 0.82
Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats. J Exp Med (1978) 0.82
B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease. J Virol (1995) 0.82
Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1997) 0.82
Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis. J Neuroimmunol (1999) 0.81
Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus. J Neurovirol (2001) 0.80
MBP-SF, a prominent serum factor in suckling Lewis rats that additively inhibits the primary binding of myelin basic protein (MBP) to syngeneic anti-MBP antibodies. Immunochemistry (1978) 0.80
Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem. Trans Am Clin Climatol Assoc (1978) 0.79
Antigenic modulation: a mechanism of viral persistence. Prog Brain Res (1983) 0.79
Rapid accumulation of measles virus leader RNA in the nucleus of infected HeLa cells and human lymphoid cells. J Virol (1991) 0.78
Immune responses against myelin basic protein and/or galactocerebroside cross-react with viruses: implications for demyelinating disease. Curr Top Microbiol Immunol (1989) 0.77
Theiler's murine encephalomyelitis virus contrasts with encephalomyocarditis and foot-and-mouth disease viruses in its functional utilization of the StopGo non-standard translation mechanism. J Gen Virol (2012) 0.77
Lack of correlation of Theiler's virus binding to cells with infection. J Neurovirol (1997) 0.77
Immunity to viruses. Curr Opin Immunol (1990) 0.75
Lack of suppressive effect of alpha-foetoprotein on development of experimental allergic encephalomyelitis in rats. Nature (1977) 0.75
DNA immunization and central nervous system viral infection. Adv Virus Res (2001) 0.75
Characterization of a murine central nervous system-derived cell line: infectability and presentation of viral antigen. J Neuroimmunol (1994) 0.75
Immunity to viruses. Curr Opin Immunol (1989) 0.75
Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1993) 0.75